{"id":"W3211113743","doi":"10.1136/ijgc-2021-003144","title":"ADAGIO: a phase IIb international study of the Wee1 inhibitor adavosertib in women with recurrent or persistent uterine serous carcinoma","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Medicine; Serous carcinoma; Serous fluid; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Oncology; Internal medicine; Carcinoma; Carcinosarcoma; Gynecology; Phases of clinical research; Clinical trial; Cancer; Ovarian cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000198588,0.0001614937,0.0004514093,0.0001564441,0.00002820753,0.00002552436,0.0003575568,0.00006052346,0.003058665],"category_scores_gemma":[0.0004107133,0.00008102772,0.0001669284,0.0003662476,0.00006297312,0.0001029749,0.0001686366,0.0003409129,0.000001394953],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001318789,"about_ca_system_score_gemma":0.0005313706,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001174418,"about_ca_topic_score_gemma":0.0006726041,"domain_scores_codex":[0.9977409,0.0001118474,0.0006849535,0.0002190485,0.001049028,0.0001942791],"domain_scores_gemma":[0.9980987,0.0001783965,0.0004217197,0.0001341286,0.001021583,0.0001454921],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1304678,0.03494005,0.6300516,0.00009668932,0.004818338,0.009297194,0.004496956,0.0006889569,0.004879767,0.00003735498,0.0007409211,0.1794844],"study_design_scores_gemma":[0.0676293,0.0228658,0.8894022,0.0005210458,0.0002772493,0.0009127739,0.005227104,0.0001106855,0.002488997,0.00005611269,0.01028431,0.0002244214],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928317,0.0004886382,0.000004715948,0.00422927,0.00182616,0.0002905601,0.00004392108,0.000004789189,0.000280254],"genre_scores_gemma":[0.9979044,0.0002162343,0.00009275155,0.0007807619,0.0004539496,0.00006123622,0.000003687832,0.00001056516,0.0004763732],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2593506,"threshold_uncertainty_score":0.9978527,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04614336769951693,"score_gpt":0.3626149689393576,"score_spread":0.3164716012398406,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}